期刊文献+

帕金森病脑多巴胺转运体代谢与黑质超声对照研究 被引量:5

Comparative study on the diagnostic value of positron emission tomography and transcranial sonography in the diagnosis of Parkinson disease
原文传递
导出
摘要 目的 观察帕金森病(PD)患者黑质超声(TCS)与脑多巴胺转运体(DAT)代谢脑正电子发射计算机断层显像(PET)是否具有一致性.方法 本研究连续筛选2012年3-10月在天坛医院就诊的拟诊帕金森病患者,进行脑11C-CFT-PET显像和黑质超声检查,应用Kappa一致性分析检验TCS与PET结果的一致性.结果 53例患者完成了TCS与DAT-PET检查,TCS相对于PET检查的灵敏度68.75%,特异度40.00%,阳性预测值91.67%,阴性预测值11.76%,PET与TCS一致性检验Kappa值为0.042,P=0.69,P >0.05.结论 对于临床诊断PD的患者,TCS结果阳性对PET阳性有较高预测价值,而TCS结果阴性时,不能排除PD可能,需要行DAT-PET检查进一步明确诊断. Objective To evaluate the consistency of dopamine transporter (DAT) positron emission tomography (PET) versus transcranial sonography (TCS) of Parkinson disease (PD) patients.Methods A total of 53 clinically diagnosed idopathic PD patients from Beijing Tiantan Hospital underwent 11C-CFT PET and transcranial sonography (TCS).Asymmetric reduced dopaminergic function was a positive result of PET while unilateral hyperechoic area larger than 0.2 cm2 a positive result of TCS.Kappa test was used to evaluate the consistency of two methods.Results Among them,36 patients (67.92%) were TCS positive while 17 patients (32.08%) TCS negative.There were 48 patients (90.57%) with positive PET whereas PET was negative for 5 patients (9.43%).TCS and PET were both positive in 33 patients (62.26%) while 2 (3.77%) yielded a double negative result.As compared with the PET results,the sensitivity,specificity,positive predictive value and negative predictive value of TCS were 68.75%,40.00%,91.67% and 11.76% respectively.For Kappa test,Kappa =0.042,P =0.690,P 〉 0.05.It inferred a poor consistency.Conclusion TCS has a high predictive value for PET positive PD patients.For clinically diagnosed PD patients,a positive TCS result highly predicts PD without DAT-PET.However a negative TCS result can not rule out the possibility of PD.DAT-PET needs to be performed for further confirmation.
出处 《中华医学杂志》 CAS CSCD 北大核心 2013年第25期1944-1947,共4页 National Medical Journal of China
基金 北京市教育委员会科技计划重点项目(KZ201210025028) 北京市科技计划项目.首都临床特色应用研究(Z11110005880000) 北京市卫生系统高层次卫生技术人才培养计划(2011-3-022)
关键词 帕金森病 多巴胺转运体 正电子发射断层显像 黑质 经颅超声 Parkinson disease Dopamine transporter PET Substantia nigra Transcranialsonography
  • 相关文献

参考文献19

  • 1Becker G, Seufert J, Bogdahn U, et al. Degeneration of substantia nigra in chronic Parkinson' s disease visualized by transcranial color-coded real-time sonography. Neurology, 1995, 45 : 182-184.
  • 2Berg D, Siefker C, Ruprecht-Dtirfler P, et al. Relationship of substantia nigra echogenicity and motor function in elderly subjects. Neurology, 2001,56 : 13-17.
  • 3Walter U, Wittstock M, Benecke R, et al. Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease. J Neural Transm, 2002, 109: 191-196.
  • 4Kassiou M, Banati R, Holsinger RM, et al. Challenges in molecular imaging of Parkinson's disease: a brief overview. Brain Res Bull, 2009, 78:105-108.
  • 5Gaenslen A, Unmuth B, Godau J, et al. The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study. Lancet Neurol, 2008, 7:417-424.
  • 6Vlaar AM, de Nijs T, van Kroonenburgh MJ, et al. The predictive value of transcranial duplex sonography for the clinical diagnosis in undiagnosed parkinsonian syndromes: comparison with SPECT scans. BMC Neurol, 2008, 8:42.
  • 7Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry, 1988, 51:745-752.
  • 8Berg D, Siefker C, Becker G. Echogenicity of the substantia nigra in Parkinson' s disease and its relation to clinical findings. J Neurol, 2001,248:684-689.
  • 9Stoffers D, Booij J, Bosscher L, et al. Early-stage [ 12311 beta- CIT SPECT and long-term clinical follow-up in patients with an initial diagnosis of Parkinson's disease. Eur J Nucl Med Mol Imaging, 2005, 32:689-695.
  • 10Laukait K, Rastenyt D, Surkiene D, et al. Specificity of transcranial sonography in parkinson spectrum disorders in comparison to degenerative cognitive syndromes. BMC Neurol, 2012, 12:12.

同被引文献26

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部